MDWD MediWound Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: MDWD

Price (delayed)

$14.45

Market cap

$186.03M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.27

Enterprise value

$149.51M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 9

mediwound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe ...

Highlights
The company's gross margin rose by 36% YoY and by 2.1% QoQ
The company's quick ratio rose by 10% YoY
The equity rose by 32% year-on-year but it has declined by 5% since the previous quarter
MDWD's gross profit is down by 13% since the previous quarter but it is up by 2.7% year-on-year
MediWound's debt has increased by 26% YoY
MediWound's revenue has decreased by 25% YoY and by 15% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.mediwound.com
Peers: JNJ TEVA

Key stats

What are the main financial stats of MDWD

MDWD stock price

How has the MediWound stock price performed over time
Intraday
5.24%
1 week
-0.76%
1 month
-16.28%
1 year
-33.41%
YTD
-21.72%
QTD
-10.3%

Financial performance

How have MediWound's revenue and profit performed over time
Revenue
$14.48M
Gross profit
$2.84M
Operating income
-$28.47M
Net income
-$26.11M
Gross margin
19.6%
Net margin
-180.3%
The company's operating margin has shrunk by 81% YoY and by 32% QoQ
MediWound's net margin has shrunk by 63% YoY and by 28% QoQ
MDWD's operating income is down by 36% YoY and by 13% QoQ
The company's gross margin rose by 36% YoY and by 2.1% QoQ

Price vs fundamentals

How does MDWD's price correlate with its fundamentals

Growth

What is MediWound's growth rate over time

Valuation

What is MediWound stock price valuation
P/E
N/A
P/B
4.48
P/S
12.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.33
The EPS has declined by 9% year-on-year and by 8% since the previous quarter
MDWD's P/B is 60% below its 5-year quarterly average of 10.5 and 31% below its last 4 quarters average of 6.2
The equity rose by 32% year-on-year but it has declined by 5% since the previous quarter
The P/S is 94% higher than the 5-year quarterly average of 6.3 and 4.4% higher than the last 4 quarters average of 11.7
MediWound's revenue has decreased by 25% YoY and by 15% from the previous quarter

Efficiency

How efficient is MediWound business performance
The return on sales has declined by 28% year-on-year and by 14% since the previous quarter
MDWD's ROE is up by 9% YoY but it is down by 2.1% QoQ
MDWD's ROIC is up by 9% since the previous quarter but it is down by 3% year-on-year
The ROA has contracted by 6% from the previous quarter and by 3.2% YoY

Dividends

What is MDWD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MDWD.

Financial health

How did MediWound financials performed over time
The company's total assets is 107% higher than its total liabilities
The company's total assets rose by 16% YoY but it fell by 7% QoQ
MDWD's current ratio is up by 12% year-on-year and by 3.4% since the previous quarter
MediWound's debt is 80% lower than its equity
The equity rose by 32% year-on-year but it has declined by 5% since the previous quarter
MediWound's debt has increased by 26% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.